These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 14697789)

  • 41. New tissue schizontocidal antimalarial drugs.
    Davidson DE; Ager AL; Brown JL; Chapple FE; Whitmire RE; Rossan RN
    Bull World Health Organ; 1981; 59(3):463-79. PubMed ID: 6976854
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 4-aminoquinoline analogues and its platinum (II) complexes as antimalarial agents.
    de Souza NB; Carmo AM; Lagatta DC; Alves MJ; Fontes AP; Coimbra ES; da Silva AD; Abramo C
    Biomed Pharmacother; 2011 Jul; 65(4):313-6. PubMed ID: 21704476
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Single dose curative and prophylactic efficacy of antimalarial drugs against multi-resistant Plasmodium yoelii nigeriensis.
    Shukla B; Dutta GP
    J Commun Dis; 1988 Sep; 20(3):175-84. PubMed ID: 3256563
    [No Abstract]   [Full Text] [Related]  

  • 44. Blood schizontocidal activity of WR 238605 (Tafenoquine) against Plasmodium cynomolgi and Plasmodium fragile infections in rhesus monkeys.
    Puri SK; Dutta GP
    Acta Trop; 2003 Apr; 86(1):35-40. PubMed ID: 12711101
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Azithromycin: antimalarial profile against blood- and sporozoite-induced infections in mice and monkeys.
    Puri SK; Singh N
    Exp Parasitol; 2000 Jan; 94(1):8-14. PubMed ID: 10631075
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Orally active 1,2,4-trioxanes: synthesis and antimalarial assessment of a new series of 9-functionalized 3-(1-arylvinyl)-1,2,5-trioxaspiro[5.5]undecanes against multi-drug-resistant plasmodium yoelii nigeriensis in mice.
    Singh C; Malik H; Puri SK
    J Med Chem; 2006 May; 49(9):2794-803. PubMed ID: 16640340
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antimalarials. 11. Synthesis of 3- and 5-aminoquinolines as potential antimalarials.
    Khan MS; LaMontagne MP
    J Med Chem; 1979 Aug; 22(8):1005-8. PubMed ID: 114654
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro and in vivo activities of atalaphillinine and related acridone alkaloids against rodent malaria.
    Fujioka H; Nishiyama Y; Furukawa H; Kumada N
    Antimicrob Agents Chemother; 1989 Jan; 33(1):6-9. PubMed ID: 2653215
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antimalarial activity of floxacrine (HOE 991) II: Studies on causal prophylactic and blood schizontocidal action of floxacrine and related dihydroacridinediones against Plasmodium yoelii and P. berghei.
    Raether W; Fink E
    Ann Trop Med Parasitol; 1982 Oct; 76(5):507-16. PubMed ID: 6760821
    [No Abstract]   [Full Text] [Related]  

  • 50. Geraniol-derived 1,2,4-trioxanes with potent in-vivo antimalarial activity.
    Singh C; Gupta N; Puri SK
    Bioorg Med Chem Lett; 2003 Oct; 13(20):3447-50. PubMed ID: 14505646
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antimalarial herbs against chloroquine-resistant P. yoelii nigeriensis in mice.
    Kimbi HK; Fagbenro-Beyioku AF; Oyibo WA
    Indian J Malariol; 1998 Mar; 35(1):35-8. PubMed ID: 10319560
    [No Abstract]   [Full Text] [Related]  

  • 52. Plasmodium yoelii nigeriensis: biological mechanisms of resistance to chloroquine.
    Beauté-Lafitte A; Altemayer-Caillard V; Chabaud AG; Landau I
    Parasite; 1994 Sep; 1(3):227-33. PubMed ID: 9140489
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antimalarial activity of Floxacrine (HOE 991) I. Studies on blood schizontocidal action of Floxacrine against Plasmodium berghei, P. vinckei and P. cynomolgi.
    Raether W; Fink E
    Ann Trop Med Parasitol; 1979 Dec; 73(6):505-26. PubMed ID: 120142
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clarithromycin, a cytochrome P450 inhibitor, can reverse mefloquine resistance in Plasmodium yoelii nigeriensis- infected Swiss mice.
    Tripathi R; Pandey SK; Rizvi A
    Parasitology; 2011 Aug; 138(9):1069-76. PubMed ID: 21756423
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Orally active amino functionalized antimalarial 1,2,4-trioxanes.
    Singh C; Malik H; Puri SK
    Bioorg Med Chem Lett; 2004 Jan; 14(2):459-62. PubMed ID: 14698181
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessment of causal prophylactic activity in Plasmodium berghei yoelii and its value for the development of new antimalarial drugs.
    Fink E
    Bull World Health Organ; 1974; 50(3-4):213-22. PubMed ID: 4155355
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antimalarial and antiplasmodial activity of husk extract and fractions of Zea mays.
    Okokon JE; Antia BS; Mohanakrishnan D; Sahal D
    Pharm Biol; 2017 Dec; 55(1):1394-1400. PubMed ID: 28320254
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The chemotherapy of rodent malaria. LII. Response of Plasmodium yoelii ssp. NS to mefloquine and its enantiomers.
    Peters W; Robinson BL; Mittelholzer ML; Crevoisier C; Stürchler D
    Ann Trop Med Parasitol; 1995 Oct; 89(5):465-8. PubMed ID: 7495359
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protective activity of biflavanones from Garcinia kola against Plasmodium infection.
    Konziase B
    J Ethnopharmacol; 2015 Aug; 172():214-8. PubMed ID: 26129936
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of the antimalarial activity of new compounds against Plasmodium falciparum in vitro, and Plasmodium berghei in vivo.
    Tedlaouti F; Gasquet M; Delmas F; Timon-David P; Madadi NE; Vanelle P; Maldonado J
    J Pharm Belg; 1990; 45(5):306-10. PubMed ID: 2086754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.